These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12449719)

  • 1. Low molecular weight heparin for venous thromboembolism prophylaxis in urologic oncologic surgery.
    Sawczuk IS; Williams D; Chang DT
    Cancer Invest; 2002; 20(7-8):889-92. PubMed ID: 12449719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy.
    Macdonald RL; Amidei C; Lin G; Munshi I; Baron J; Weir BK; Brown F; Erickson RK; Hekmatpanah J
    Neurosurgery; 1999 Aug; 45(2):245-51; discussion 251-2. PubMed ID: 10449068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery.
    De A; Roy P; Garg VK; Pandey NK
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):57-61. PubMed ID: 19844176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of venous thromboembolism in surgery, in laparoscopic surgery, in venous surgery and in urology].
    Gumulec J; Penka M; Bezdĕk R; Czudek S; Stursa M; Wróbel M; Brejcha M; Klodová D; Sumná E; Králová S
    Vnitr Lek; 2006 Mar; 52 Suppl 1():41-50. PubMed ID: 16637449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood coagulation and thrombosis in patients with ovarian malignancy.
    von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
    Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of Prophylaxis Protocols for Venous Thromboembolism in Neurosurgery: Results from a Prospective Comparative Study on Low-Molecular-Weight Heparin, Elastic Stockings, and Intermittent Pneumatic Compression Devices.
    Chibbaro S; Cebula H; Todeschi J; Fricia M; Vigouroux D; Abid H; Kourbanhoussen H; Pop R; Nannavecchia B; Gubian A; Prisco L; Ligarotti GKI; Proust F; Ganau M
    World Neurosurg; 2018 Jan; 109():e510-e516. PubMed ID: 29033376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism.
    Wellington K; McClellan K; Jarvis B
    Drugs; 2001; 61(8):1185-209. PubMed ID: 11465877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of once-daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients.
    Cothren CC; Smith WR; Moore EE; Morgan SJ
    World J Surg; 2007 Jan; 31(1):98-104. PubMed ID: 17180563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
    Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
    Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial.
    McLeod RS; Geerts WH; Sniderman KW; Greenwood C; Gregoire RC; Taylor BM; Silverman RE; Atkinson KG; Burnstein M; Marshall JC; Burul CJ; Anderson DR; Ross T; Wilson SR; Barton P;
    Ann Surg; 2001 Mar; 233(3):438-44. PubMed ID: 11224634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial.
    Kakkar VV; Boeckl O; Boneu B; Bordenave L; Brehm OA; Brücke P; Coccheri S; Cohen AT; Galland F; Haas S; Jarrige J; Koppenhagen K; LeQuerrec A; Parraguette E; Prandoni P; Roder JD; Roos M; Rüschemeyer C; Siewert JR; Vinazzer H; Wenzel E
    World J Surg; 1997 Jan; 21(1):2-8; discussion 8-9. PubMed ID: 8943170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparins for venous thromboembolism.
    Drug Ther Bull; 1998 Apr; 36(4):25-9. PubMed ID: 9684414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: A randomized trial of prophylaxis with low--molecular weight heparin.
    Michot M; Conen D; Holtz D; Erni D; Zumstein MD; Ruflin GB; Renner N
    Arthroscopy; 2002 Mar; 18(3):257-63. PubMed ID: 11877611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis.
    Rasmussen MS
    Cancer Treat Rev; 2002 Jun; 28(3):141-4. PubMed ID: 12234565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin for the prevention of deep venous thrombosis after total knee arthroplasty: A systematic review and meta-analysis.
    Xia ZN; Zhou Q; Zhu W; Weng XS
    Int J Surg; 2018 Jun; 54(Pt A):265-275. PubMed ID: 29733996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery.
    Fricker JP; Vergnes Y; Schach R; Heitz A; Eber M; Grunebaum L; Wiesel ML; Kher A; Barbier P; Cazenave JP
    Eur J Clin Invest; 1988 Dec; 18(6):561-7. PubMed ID: 2852111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial.
    Haas S; Flosbach CW
    Semin Thromb Hemost; 1993; 19 Suppl 1():164-73. PubMed ID: 8395721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.